CSIMarket
 
Bluejay Diagnostics Inc  (NASDAQ: BJDX)
 

Bluejay Diagnostics Inc's Customers Performance

BJDX



 
BJDX's Source of Revenues

List of BJDX Customers




for the same period Bluejay Diagnostics Inc

List of BJDX Customers





Bluejay Diagnostics Inc's Comment on Sales, Marketing and Customers



The company plans to generate recurring revenue by selling single-use diagnostic test cartridges for the Symphony platform. The Symphony platform enables rapid and accurate measurement of diagnostic biomarkers in blood and is intended for markets requiring mobile and user-friendly diagnostic solutions. It is designed for tests related to sepsis and potentially other diseases or conditions. The company aims to increase annual revenue per customer by expanding test menus and utilization. Manufacturing of the Symphony analyzers and cartridges will be conducted by Sanyoseiko, a contract manufacturing organization, under a master supply and service agreement.


  News about Bluejay Diagnostics Inc Contracts

Bluejay Diagnostics' Revolutionary Symphony IL-6 Moves Closer to Transforming Sepsis Diagnosis and Patient Care

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)Bluejay Diagnostics, a leading biotechnology company, has recently made an exciting announcement regarding the initiation of a multicenter clinical study called SYMON, which aims to evaluate the effectiveness of their innovative diagnostic tool, Symphony IL-6, in sepsis patients. This study marks a significant milestone for the company and highlights its commitment to advancing medical diagnostics.Sepsis, a life-threatening condition caused by the body s response to an infection, is a leading cause of mortality and morbidity worldwide. It is crucial to diagnose sepsis accurate...




Bluejay Diagnostics Inc’s Comment on Sales, Marketing and Customers


The company plans to generate recurring revenue by selling single-use diagnostic test cartridges for the Symphony platform. The Symphony platform enables rapid and accurate measurement of diagnostic biomarkers in blood and is intended for markets requiring mobile and user-friendly diagnostic solutions. It is designed for tests related to sepsis and potentially other diseases or conditions. The company aims to increase annual revenue per customer by expanding test menus and utilization. Manufacturing of the Symphony analyzers and cartridges will be conducted by Sanyoseiko, a contract manufacturing organization, under a master supply and service agreement.








BJDX's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Bluejay Diagnostics Inc 1.91 0.00 -7.34 6
SUBTOTAL 0.00 0.00 0.00 -

Sources: Bluejay Diagnostics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Bluejay Diagnostics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Bluejay Diagnostics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.